Learn / GRFS
NASDAQ: GRFS
Grifols SA (GRFS) stock, explained like you're 5
Grifols SA trades on the Nasdaq under the ticker GRFS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.1 billion dollars.
- Ticker
- GRFS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 5.1 billion dollars
Is Grifols SA a small, medium or large cap company?
No. Grifols SA is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Grifols SA makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves GRFS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Grifols, S.A. (GRFS) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Grifols, S.A. (GRFS) stock price, news, quote and history (Yahoo Finance Australia)
- Grifols, S.A. (NASDAQ:GRFS) Shares Shorted: Short Interest Up 105.0% in September (MarketBeat)
- Grifols, S.A.: Dividend historical data and projections (www.marketscreener.com)
- Grifols: Plasma Self Sufficiency Is The Mispriced Catalyst (NASDAQ:GRFS) (Seeking Alpha)
Follow GRFS in your daily brief
Each trading day at 5 PM ET we post what happened to Grifols SA and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow GRFS
Questions about Grifols SA stock
What does Grifols SA do?
Grifols SA trades on the Nasdaq under the ticker GRFS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 5.1 billion dollars.
What is the ticker symbol for Grifols SA?
Grifols SA trades under the ticker GRFS on the Nasdaq.
What is Grifols SA's market cap?
Grifols SA is a mid cap stock with a market cap of about 5.1 billion dollars.
How does Grifols SA make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves GRFS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow GRFS stock every day?
Add GRFS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.